We finally investigated whether PVS volume fraction could predict PD disease severity, measured by both biological markers, such as CSF alpha-synuclein at baseline, longitudinal beta-amyloid, t-Tau and phosphorylated Tau (p-Tau), and cognitive scores after five years. Here, MAPT is linked to Parkinson disease.